Local Globe Latitude
Based on the limited information available, LocalGlobe Latitude positions itself as a long-term partner for founders, focusing on pre-seed and seed stages. They appear to invest across various sectors, with a portfolio including companies in fintech, insurance, travel, and real estate. Their investment strategy seems to involve both LocalGlobe and Latitude funds, suggesting a possible tiered investment approach based on stage or geography. From their portfolio companies, they may prioritize companies with strong growth potential and innovative solutions. The 'Live at Phoenix Court' section indicates a focus on community and providing value through events and networking.
LocalGlobe VC
Based on the website content provided, LocalGlobe positions itself as a "trusted long-term partner for founders from pre-seed and seed." While a comprehensive investment thesis isn't explicitly stated, the firm seems to prioritize early-stage investments with a focus on providing ongoing support and building lasting relationships with the companies they back. Their involvement in multiple companies across diverse sectors suggests an opportunistic approach within their defined stage and geographic preferences. They also appear to have a strong network, as evidenced by the co-investors they work with and the events they host.
MOC Capital
MOC Capital backs pre-seed and seed stage platforms of tomorrow that democratize market access and enhance efficiency through network effects across Europe.
Magma Partners
Magma Partners invests in top entrepreneurs in Latin America, focusing on increasing their chances of success. They aim to support founders solving the region's biggest problems by building scalable technology businesses in large markets. While they are known for fintech, insurtech, and marketplaces, they consider themselves a generalist fund. They invest from pre-seed to Series A, aiming to be a first investor but also participating in later rounds if they missed the earlier stages. They utilize a 'Magma Memo' system to efficiently receive and review startup information, focusing on the team, the startup, and its traction. They have invested in 125+ startups with $80M+, and back founders solving Latin America's biggest problems by building scalable, technology businesses in big markets. The firm has built a fully distributed team across Latin America to support entrepreneurs. They provide a team of entrepreneurs and former early employees of Silicon Valley and Latin American startups to support founders on their journeys.
Masia
Masia is a globally connected angel VC fund based in Barcelona. Their investment strategy focuses on early-stage companies (pre-seed and seed) within AI and Frontier Technologies. They aim to be a collaborative and founder-first investor, providing not only capital (€125K-€250K) but also access to their network of founders and LPs for go-to-market, hiring, sales, and fundraising support. Masia spun out from Aldea Ventures, a Fund of Funds backing Europe's best specialized VCs, leveraging this connection to offer warm introductions to later-stage investors. They pride themselves on a fast and direct approach, providing quick decision-making with the rigor of a regulated fund.
Meneldor
Meneldor provides investors with the opportunity to co-invest with specialists in early-stage Biotech and Pharma companies, specifically from pre-seed to Phase 2 clinical trials. Recognizing the inherent risks and complexity of the biotech sector, Meneldor emphasizes rigorous due diligence. They conduct thorough scientific analysis of potential portfolio companies. A comprehensive assessment of other critical aspects, including intellectual property, medical need, market size, competition, risk profile, management team, financial requirements, and valuation, is performed, only investing when all selection criteria are met. Their investment strategy relies on a rigorous scientific and commercial assessment of early stage Biotech and Pharma companies. It is implied that they leverage their own internal expertise and/or specialist networks to evaluate the potential of new treatments, drugs and therapeutic approaches. By thoroughly evaluating the scientific merit of a company's technology, along with a comprehensive assessment of the business case, IP, and market opportunity, Meneldor aims to mitigate the risk associated with early stage biotech investments. They seek to provide access to investment opportunities that are typically difficult for individual investors to access directly, partnering with those who possess specialized expertise in biotechnology and pharmaceuticals to select and manage investments in this sector. The firm carefully analyzes the science, intellectual property, management, and other factors of biotech companies before deciding to invest. Once a potential target is vetted, they invite their investors to participate in the investment.
Microtraction
Microtraction is an early-stage venture capital firm focused on investing in African startups at the pre-seed stage. They aim to be the first institutional check for ambitious founders building high-growth, technology-driven businesses targeting billion-dollar markets. Microtraction invests $100,000 for 7% equity in their portfolio companies. The firm is sector agnostic, indicating a willingness to invest across diverse industries. However, they prioritize founders who demonstrate resourcefulness, intelligence, and the potential to build scalable businesses. Microtraction provides not only capital but also mentorship and access to a community of other venture-backed founders, leading investors, and subject matter experts to support portfolio growth. Microtraction's investment philosophy centers around 'Founder Love,' emphasizing a commitment to supporting founders through challenges and successes. They provide an open application process, allowing founders to apply for funding year-round without needing introductions. The firm also helps founders develop a strategy for raising their seed round within 12-18 months, given the fulfillment of certain company metrics. Their limited partners (LPs) include other VCs and angel investors who are actively looking for promising African startups. Microtraction differentiates itself by operating as a team of founders and operators who share the entrepreneurial mindset, providing startups with direct access to capital for scaling. They emphasize the diverse experience of their investors and the ability to unlock access to influential individuals and companies.
Motivate Ventures
Motivate Ventures empowers ambitious founders to realize their vision of tomorrow. They invest across the earliest stages of a company’s lifecycle, providing experience, connections, and capital to the leaders of tomorrow’s greatest companies. They are early stage specialists, focusing on pre-seed and seed stage companies. They actively work with high-caliber founders to co-create and bring ideas to life. Motivate Ventures also invests in and supports formidable emerging pre-seed and seed stage VC Funds. MVC invests in optimism, ingenuity, and humanity’s insatiable desire to creatively improve. They back incredible founders with strong domain knowledge who are tackling real, durable problems. They seek opportunities with very high growth potential in large and growing markets. Lauren Deluca at Motivate focuses on fintech and B2B software at the earliest stages – from idea through Seed – often supporting founders with incredible domain expertise and a non-consensus industry worldview.
NFX Bio
NFX Bio invests in Scientist-Founders who combine deep biological expertise with technological innovation (e.g., AI/ML, automation, digital biology) to address complex global problems in health and food systems. The firm emphasizes rapid decision-making, scientific-business alignment, and leading investment rounds. Key themes include the shift from analog to digital biology, human design to AI/ML-driven solutions, and manual processes to high-throughput automation.
NP-Hard Ventures
NP-Hard Ventures is a European pre-seed fund focused on investing in ambitious founders tackling the most challenging problems. While a full investment thesis requires further exploration of the linked command, the landing page suggests a focus on technically complex and difficult-to-solve problems.
Network Venture Partners
Network Venture Partners is a venture capital firm distinguished by its origin and operation: it was founded by entrepreneurs for entrepreneurs. It blends the operational knowledge acquired from scaling a global business with the resources of entrepreneurial investors and family offices. The firm aims to invest in startups with high potential, playing an active role in helping them scale and achieve significant business growth. They position themselves as co-founders, providing support through their experience and network. They are actively searching for exceptional entrepreneurs to support throughout their entire journey, aiming to accelerate and scale their businesses, offering long-term commitment beyond financial investment, seen through consistent weekly engagement with the founders. Network Venture Partners focuses on product-led tech companies with the potential for global growth, regardless of the industry. They prioritize investments where they can provide substantial added value as co-founders, leveraging their investor network and possessing a deep understanding of scaling businesses internationally. They focus on making a limited number of high-impact investments, concentrating their efforts on these chosen companies. They are open to backing entrepreneurs at the very beginning of their journey, including pre-seed stages, acting as a sounding board for student teams and global scale-ups alike. They emphasize their long-term commitment, supported by entrepreneurial investors and family offices that prioritize the needs of founders. This ensures that they are not driven by the need to deploy capital quickly or constrained by fixed holding periods. Their dedication is to support the growth of their portfolio companies for as long as it takes.
NewSchool VC
NewSchool.vc focuses on investing in "new school tech for old school industries." They seek founders with conviction, and prioritize companies operating in the AI, SaaS, Cyber, Robotics, and Compliance+ sectors. Their approach seems to target companies that are modernizing traditionally less technologically advanced industries, likely leading to large improvements in efficiency and productivity.
Nordic Science Investments
Nordic Science Investments (NSI) partners with founders to transform groundbreaking university research into successful startups. They are committed to both profit and impact, accelerating the journey from scientific discovery to market, creating meaningful career opportunities, and driving technological advancement. NSI invests in early-stage, science-based startups and university spinouts in the New Nordics, focusing on bridging the gap between academia and commercialization. They derisk teams for further investment and co-invest with others. Their mission is to turn hidden scientific discoveries into groundbreaking innovations that redefine industries and improve lives. They partner with founders and universities who share a vision of promoting global sustainability and well-being. NSI fuels growth in disruptive sectors such as advanced materials, AI-driven technologies, and synthetic biology, empowering innovative solutions that address global challenges. They are dedicated to creating a lasting, positive impact on society by advancing science that truly matters. NSI excels in early-stage investing, supporting ventures from day one. Their value extends beyond capital, offering synergistic deals and a partner network managing similar vehicles in the UK and North America. This access accelerates growth and boosts outcomes. They strengthen Tech Transfer Offices’ commercialization efforts by partnering with universities, generating superb deal flow through their IP screening expertise. They also attract top spinout CEOs who value their specialist approach, helping mitigate early-phase investment risks. NSI focuses on investing in companies with the potential to disrupt, challenge the status quo, and even create entirely new markets. They back startups that tackle problems previously thought unsolvable, especially those originating as university spinouts.
Norrsken Evolve
Norrsken Evolve is a pre-seed fund focused on supporting early-stage founders in Europe who are building resilient and sustainable solutions to address critical global challenges. The firm aims to turn crisis into opportunity by investing in companies redefining industries like energy, manufacturing, transportation, construction, food production, healthcare, information security, and democratic safeguards. They believe Europe has the science, innovation, talent, and investor demand to foster the next wave of global technology leaders. They target founders who understand the severity of current challenges and are determined to create a positive impact on the world. Norrsken Evolve provides capital, a world-class in-person program, and a strong network to accelerate the growth of its portfolio companies. The firm emphasizes that economies, industries, and ways of living must evolve in the face of unprecedented risks, and the founders they back will lead this evolution. They seek visionary entrepreneurs capable of building companies that can positively impact 1 billion lives across the globe and have the potential to grow into impact unicorns. Their investment strategy focuses on pre-seed stage companies with the potential to revolutionize various sectors and address environmental, social, and governance (ESG) concerns. They are looking for companies that will redefine how we generate energy, rebuild manufacturing, move goods, construct buildings, produce food, treat our sick, secure our information, protect democracy, and safeguard our societies from climate disruption. Norrsken Evolve aims to lead the evolution necessary for Europe to step up and address the challenges the continent is facing. They invest in founders with a focus on building a resilient and sustainable future for Europe, providing them with the necessary resources and support to achieve their goals and make a significant positive impact on the world.
Novalis Biotech
Novalis Biotech is an early-stage venture capital investor focusing on enabling technologies in the life sciences. They aim to support innovative healthcare concepts from the incorporation stage, emphasizing capital-light platform technologies and close customer interaction early in the company's lifecycle. The firm focuses on funding, professional/academic connections, and business strategy to create value for all stakeholders, supporting early-stage startups from pre-seed to Series A stages.
Obuda Uni Venture Capital
Obuda Uni Venture Capital (OUVC) is a 10 billion HUF venture capital and venture studio affiliated with Obuda University. They focus on early-stage ventures, aiming to add value by providing both financial investment and go-to-market support. OUVC acts as a gateway and link to the competencies of the university, serving both internal and external startups and partners. They aim to build viable innovative businesses through a combination of capital, technical validation, mentorship, professional collaboration opportunities, and business development support. The firm's investment strategy targets a wide range of opportunities, including innovations originating from the university as well as more mature companies with Hungarian relevance. They aim to foster value creation, recognizing the potential impact of supporting ventures in their initial phases. OUVC prioritizes companies that solve real problems, even outside of their core focus areas. The value-add provided goes beyond just financial resources; the firm also helps portfolio companies through mentorship, opening opportunities for industry collaboration, and assisting in business development. They invest in companies in the pre-seed and seed stages. OUVC's team includes individuals with experience in venture capital and connections to Óbuda University, which gives them access to academic research and resources and access to talented students/recent graduates.
Onstage
Onstage operates an events ecosystem aimed at simplifying the fundraising journey for startups and VCs. Their primary event, Demo Day, occurs bi-annually and is designed to connect pre-seed to Series A startups with over 300 leading VC funds. The process involves a streamlined application, VC introductions, the announcement of the Onstage Top 100, and a live Demo Day in London where the top 1% of applicants pitch. All applicants get exposure to VCs. Onstage also hosts "Deploy," an in-person summit for emerging and established venture fund managers to pitch their funds to a curated group of LPs. Onstage emphasizes efficiency, meritocracy, transparency, and collaboration in the startup ecosystem, aiming to provide an equal playing field for founders and funders and perfect information to all stakeholders.
Opal Ventures
Opal Ventures is a thesis-driven venture capital firm focused on backing early-stage health tech startups in the US. They aim to transform the healthcare industry by investing in high-conviction, pre-seed stage companies. They prioritize building a strong relationship with their portfolio companies, fostering trust and transparency, and offering support beyond capital investment. The firm is operator-led, with the team offering expertise and hands-on assistance to founders. Opal Ventures focuses on being the first check into promising health tech startups. Their investment strategy involves providing a laser-focused approach on early-stage health tech, leveraging a broad network of advisors to support founders from the earliest stages of building. They offer operational support to their portfolio companies. Their stated goal is to build an open and trusting relationship with founders, making them the first point of contact when support is needed. The firm's commitment lies in providing early-stage capital and support to health tech startups that can transform healthcare in the US. They look for opportunities to be the first investor in these companies. The team comprises experienced operators who provide honest feedback and celebrate the successes of their founders. They support founders in accelerating their journey toward success. Opal Ventures' approach to value addition is to combine their investment with operational experience and network. This enables them to offer focused support to their founders during the critical early stages of company building. They differentiate themselves by building strong founder relationships based on trust and transparency.
Owl Ventures
Owl Ventures is a global venture capital firm focused on investing in transformative learning and workforce AI companies across all stages and sectors. The firm believes education is the most powerful driver of human potential and aims to scale the world's most impactful education companies. They have a decade-long focus on EdTech and aim to not just invest but to build the market, scaling companies from pre-revenue to nine-figure businesses and coordinating M&A across their portfolio. Owl Ventures also prioritizes investments that create lasting change by expanding opportunity, driving equity, and advancing lifelong learning. The firm operates as a full-lifecycle partner, leading rounds from pre-seed through IPO and actively engaging throughout the growth cycle. They leverage their global LP network to gain access to global growth opportunities in education, workforce, and AI-driven learning, with investments spanning six continents. Their extensive portfolio of over 100 companies creates powerful synergies in distribution, talent, M&A, and insights, resulting in a network effect that benefits their portfolio companies. Owl Ventures is focused on backing bold ideas in education and work globally. They invest in companies at every stage, from pre-seed to pre-IPO, to help scale companies from their first customers to becoming global category leaders. Their portfolio spans the full learning journey, from PreK-12 and higher education to workforce development and lifelong learning, with a particular emphasis on AI-powered solutions that are reshaping how knowledge is created, shared, and scaled.
Oxford Capital
Oxford Capital is a venture capital firm based in Oxford, UK, that invests in early-stage and growth-stage companies across the UK. They focus on backing founders of innovative companies with disruptive potential, investing from pre-seed to growth and beyond. With over 25 years of experience, they have invested over £500m into over 100 companies. The firm provides individuals, families, and institutions the ability to participate in these investment opportunities. Oxford Capital aims to bridge the gap between entrepreneurs and private capital investors. The firm's strategy involves supporting companies from their earliest stages to later growth, enabling entrepreneurial successes. They are particularly interested in companies leveraging technology and science to solve complex problems. The firm's investment approach emphasizes backing companies that are creating new markets or disrupting existing ones. Oxford Capital looks for founders with a clear vision, strong execution capabilities, and the potential to build large, scalable businesses. They also focus on providing value beyond capital, offering support in areas such as strategy, operations, and fundraising. Oxford Capital actively monitors the venture capital landscape, providing commentary on industry trends and investment policy through its news and views section. They support the Enterprise Investment Scheme (EIS) as a means to encourage investment in early-stage companies. The firm has a strong emphasis on governance and sustainability in both mature and high-growth companies.
Panache Ventures
Panache Ventures is Canada’s leading pre-seed & seed fund, dedicated to backing visionary founders from day one. They aim to be the first institutional investor on the cap table, providing initial investments up to $1.5M from their $100M Fund II. Panache focuses on supporting technology founders across all sectors nationwide, with hands-on support from operators-turned-investors. They emphasize a no-ego approach, focusing on practical assistance rather than board seats. The firm's strategy revolves around identifying and investing in founders with conviction and courage, providing them with the resources and support needed to scale their companies. Panache offers more than just capital, delivering operator-led support, leveraging a network of over 100 founders who have grown with their assistance. They do not emphasize board seats but a hands-on approach to mentorship and support. Panache emphasizes a national presence, implying a focus on the Canadian market and a commitment to supporting founders across the country. They highlight their experience as former operators, suggesting a practical, hands-on approach to helping their portfolio companies overcome challenges and achieve growth. The absence of ego suggests a collaborative and founder-centric approach, prioritizing the needs of the entrepreneurs they back.
Park Rangers Capital
Park Rangers Capital is a pre-seed and seed firm that focuses on backing founders with a built-in distribution edge. Their investment philosophy is rooted in the belief that software has become a commodity and that the loneliness epidemic in the U.S. is a significant problem. They believe the strongest companies of the next decade will address both by building communities, where users belong and are deeply connected to the brand. They seek founders who are building movements early on, with companies whose members are obsessive, loyal, and deeply connected to the brand, referring to these founders as 'elephants, not unicorns.' The firm's focus extends beyond mere product creation, emphasizing the importance of community building. They aim to support founders in turning customers into members and companies into movements, recognizing that distribution, community, and authenticity are key moats in today's market. They provide support in three core areas: content & storytelling, community access, and distribution strategy. Park Rangers Capital emphasizes the use of content to distribute ideas, build trust, and connect with founders. They are a solo GP shop supported by a Chief of Staff, venture partner, fractional writer, and a network of operators. Erica Wenger, the solo GP, has experience as a serial entrepreneur and early operator.
Point Nine Capital (P9)
Point Nine invests in AI-driven startups across SaaS, B2B software, and emerging sectors like healthcare, robotics, and agriculture, focusing on pre-seed and seed-stage companies with global potential. The firm emphasizes thesis-driven investments, working closely with founders to accelerate growth and provide operational support.
Positron Ventures
Positron Ventures focuses on helping and funding Europe-based scientist-entrepreneurs who are pursuing moonshots for planetary health. They invest in scientist-entrepreneurs working on breakthroughs across the natural sciences, backing teams from day one in their pursuit of solving major global challenges. The firm often acts as the first believer and investor, offering support across all aspects of building a company. They proactively conduct deep dives in scientific niches to thoroughly understand the state of science in a given field before investing. Their investment strategy appears to be focused on early-stage, pre-seed deeptech companies. Positron Ventures aims to turn breakthrough research into successful companies by investing at the frontier of science and building systems that help deeptech founders succeed. This includes support across operations, people, communications, and LP engagement. Positron Ventures invests in deeptech funds in Europe and the US, and is launching the Positron Foundation to support high-risk, pre-commercial research.